Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight cancer using “dark antigens” in a deal worth up to €876 million ($1.07bn).

the majority of the target antigens of cancer vaccines are close to self antigens because cancer arises from uncontrolled growth of normal self cells from the individual. Individuals' T cells ...

2020年底，美国FDA紧急批准了两种mRNA疫苗（辉瑞/BioNTech联合研发的BNT162b2和Moderna公司的mRNA-1273），为新冠疫情防控提供了革命 ...

像 [18 F] RCCB6 等示踪剂能精准诊断，助力癌症诊疗，值得关注。 ### CD70 的特性及在癌症诊疗中的意义 CD70 作为一种肿瘤相关抗原（Tumor - associated antigen，TAA），在癌症研究领域备受瞩目。它在多种恶性肿瘤中呈现出异常高表达的特征，其中在透明细胞肾细胞癌 ...

Only 7 (32%) patients (median age, 56 years; range, 48-68 years) met eligibility criteria; they had measurable lesions (n = 4) or elevated cancer antigen 125 level and non-measurable lesions (n = 3).

A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...